Judgement Day, page-25

First 25 Last

Share
Profile

Follow
Wazz101

338 Posts.

0

14/04/18

17:22

Post #: 32457772
Share

Originally posted by Autosime ↑

Joseph
Yes - buffet has lost money - 400m in one company , but his point is it’s still damaging as it makes the required return from other investments that much greater

Wazz- anyone with any brains who had the 15k worth of shares would have sold on market and picked up SPP shares with the free attaching option. Having said that it’s good for short term survival but raising money at .7c is not what I call a great outcome - highly dilutionary

Expand

Actually Auto, anyone with any brains would have bought $10 worth of shares to get the entitlement and bought the full allocation from the SPP.

I'm sure there'll be plenty of Einsteins claiming to have done so after they cotton on, in a couple of months.

FPL Price at posting: 0.8¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

ASX Today: Australian shares fall as retail and banks drag on index

HAR

Haranga Resources makes strategic "Mother Lode" acquisition in US

AKN

Auking Mining Tundulu rare earth diamond hole intersects carbonatite to EOH

TGN

Tungsten has soared +700% YTD, the US is curbing its exports, and this ASX stock is targeting production in Q1CY27

MSB

Mesoblast completes Phase 3 low back pain trial treatment as pivotal readout approaches

First 25 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Judgement Day, page-25

Top Stories

ASX Today: Australian shares fall as retail and banks drag on index

Haranga Resources makes strategic "Mother Lode" acquisition in US

Auking Mining Tundulu rare earth diamond hole intersects carbonatite to EOH

Tungsten has soared +700% YTD, the US is curbing its exports, and this ASX stock is targeting production in Q1CY27

Mesoblast completes Phase 3 low back pain trial treatment as pivotal readout approaches

Featured News